Hikma Pharmaceuticals PLC Share Price and Company Fundamentals



Price
£2646
Change
24.000 (0.915%)
52 week
2132.0 - 2768.0

Last traded: Last Friday at 3:35 PM

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic, branded, and in-licensed pharmaceutical products. The company offers its products in solid, semi-solid, liquid, and injectable final dosage forms. It operates through three segments: Injectables, Generics, and Branded. The Injectables segment develops, manufactures, and sells generic injectable products primarily for use in hospitals. The Generics segment develops, manufactures, and sells oral and other non-injectable generic products for the retail market. The Branded segment develops, manufactures, markets, and sells branded generics and in-licensed products to retail and hospital markets. The company offers its products in various therapeutic areas, including anti-infective, cardiovascular, central nervous system, diabetes, oncology, pain management, anesthetic, sedative, and respiratory. It operates in the United Kingdom, the United States, the Middle East, North Africa, Europe, and internationally. The company was founded in 1978 and is based in London, the United Kingdom.

Key Metrics

PE ratio

20.31

PB ratio

285.62

Dividend yield

0.02%

Beta

-0.06

Market cap

£6.12B

Enterprise value

£6.7B

Company profile

Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Full time employees8600
Websitehttp://www.hikma.com
Mailing address1 New Burlington Place London W1S 2HR United Kingdom
Phone / Fax44 20 7399 2760 / 44 20 7399 2761

Dividends

Dividend yield

0.02%

Dividend amount

£0.50

Payout ratio

25.39%

5Y Avg. yield

1.64%

Hikma Pharmaceuticals PLC paid £0.50 dividend and the ex-dividend date was 18 Mar 2021.The dividend payout ratio is 25.39%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.HIK dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

HIK's forward dividend amount is £0.37 and the forward dividend yield is 1.39%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2021, following are the company executives and directors listed on Hikma Pharmaceuticals PLC.

NameTitleAgeTotal Pay
Engineer Said Samih Taleb DarwazahExec. Chairman633.01M
Mr. Sigurdur Oli Olafsson Ph.D.CEO & Exec. Director513.72M
Mr. Mazen Samih Taleb DarwazahExec. Vice Chairman & Pres of MENA622.16M
Mr. Khalid Waleed Hosny Al NabilsiChief Financial Officer48
Ms. Henriette NielsenExec. VP of Bus. Operations
Dr. Shahin FesharakiChief Scientific Officer
Mr. Hussein ArkhaghaChief Counsel
Mr. Bassam Wael Rushdi KanaanExec. VP of Corp. Devel. and M&A55
Ms. Susan RingdalExec. VP of Strategic Planning & Global Affairs
Ms. Majda LabadiExec. VP of Organisational Devel.

Profitability and management effectiveness

Profit margin

18.41%

Operating margin

24.43%

Return on assets

8.86%

Return on equity

20.11%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Hikma Pharmaceuticals PLC is 6.12B and its enterprise value is 6.7B. The enterprise value to revenue ratio of HIK is 2.86.

Hikma Pharmaceuticals PLC (LSE:HIK) Frequently Asked Questions

1. What is Hikma Pharmaceuticals PLC's Stock Symbol?

Hikma Pharmaceuticals PLC trades on LSE under the ticker symbol "HIK".

2. What is Hikma Pharmaceuticals PLC's stock price today?

One share of HIK stock can currently be purchased for approximately £2646.

3. How can I contact Hikma Pharmaceuticals PLC?

Hikma Pharmaceuticals PLC's mailing address is 1 New Burlington Place London W1S 2HR United Kingdom. The company can be reached via phone at 44 20 7399 2760.

4. What is Hikma Pharmaceuticals PLC's official website?

The official website of Hikma Pharmaceuticals PLC is http://www.hikma.com.